Hypofractionated, palliative radiotherapy for advanced head and neck cancer

Radiotherapy and Oncology

Volumn 89, Issue 1, 2008, Pages 51-56

  Agarwal, Jai Prakash ^a   Nemade, Bhushan ^a   Murthy, Vedang ^a   Ghosh Laskar, Sarbani ^a   Budrukkar, Ashwini ^a   Gupta, Tejpal ^a   D'Cruz, Anil ^a   Pai, Prathamesh ^a   Chaturvedi, Pankaj ^a   Dinshaw, Ketayun ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Head and neck cancer; Hypofractionated radiotherapy; Palliation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; COMPARATIVE STUDY; DISTRESS SYNDROME; DYSPHAGIA; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PAIN; PALLIATIVE THERAPY; PRIORITY JOURNAL; RADIATION DOSE; REGRESSION ANALYSIS; SKIN TOXICITY; TIME SERIES ANALYSIS; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 53049092005     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.06.007     Document Type: Article

References (24)

1. Bezjak A., Adam J., Panzarella T., et al. Radiotherapy for brain metastases: defining palliative response. Radiother Oncol 61 (2001) 71-76
2. Burns L., Chase D., and Goodwin Jr. W.J. Treatment of patients with stage IV cancer: do the ends justify the means?. Otolaryngol Head Neck Surg 97 (1987) 8-14
3. Carvalho A.L., Salvajoli J.V., and Kowalski L.P. A comparison of radiotherapy or radiochemotherapy with symptomatic treatment alone in patients with advanced head and neck carcinomas. Eur Arch Otorhinolaryngol 257 (2000) 164-167
4. Chow E., Wu J.S., Hoskin P., Coia L.R., Bentzen S.M., and Blitzer P.H. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64 (2002) 275-280
5. Corry J., Peters L.J., Costa I.D., et al. The 'QUAD SHOT' - a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiother Oncol 77 (2005) 137-142
6. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
7. Dobrowsky W., and Naude J. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers. Radiother Oncol 57 (2000) 119-124
8. Forbes K. Palliative care in patients with cancer of the head and neck. Clin Otolaryngol Allied Sci 22 (1997) 117-122
9. Fu K.K., Clery M., Ang K.K., Byhardt R.W., Maor M.H., and Beitler J.J. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09. Int J Radiat Oncol Biol Phys 32 (1995) 589-597
10. Grau C., Prakash Agarwal J., Jabeen K., et al. Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial. Radiother Oncol 67 (2003) 17-26
11. Hayter C.R., Huff-Winters C., Paszat L., Youssef Y.M., Shelley W.E., and Schulze K. A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer. Radiother Oncol 56 (2000) 329-333
12. Henk J.M., and James K.W. Comparative trial of large and small fractions in the radiotherapy of head and neck cancer. Clin Radiol 29 (1978) 611-616
13. Hodson D.I., Bruera E., Eapen L., et al. The role of palliative radiotherapy in advanced head and neck cancer. Can J Oncol 6 (1996) 54-60
14. Kowalski L.P., and Carvalho A.L. Natural history of untreated head and neck cancer. Eur J Cancer 36 (2000) 1032-1037
15. Lucente F.E. Treatment of head-and-neck carcinoma with noncurative intent. Am J Otolaryngol 15 (1994) 99-102
16. Mohanti B.K., Umapathy H., Bahadur S., Thakar A., and Pathy S. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother Oncol 71 (2004) 275-280
17. Percarpio B., and Fischer J.J. Irradiation of advanced head and neck cancer with large daily fractions. Preliminary results of a prospectively randomized clinical trial. Radiology 121 (1976) 489-490
18. Porceddu S.V., Rosser B., Burmeister B.H., et al. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment-hypo trial. Radiother Oncol 85 (2007) 456-462
19. Rao D.N., Shroff P.D., Chattopadhyay G., and Dinshaw K.A. Survival analysis of 5595 head and neck cancers - results of conventional treatment in a high-risk population. Br J Cancer 77 (1998) 1514-1518
20. Senn H.J., and Glaus A. Supportive Care in Cancer - 15 years thereafter. Support Care Cancer 10 (2002) 8-12
21. Talapatra K., Gupta T., Agarwal J., Laskar S., Shrivastava S., and Dinshaw K. Palliative radiotherapy in head and neck cancers: evidence based review. Indian J Palliat Care 12 (2006) 44-50
22. Trotti A., Pajak T.F., Gwede C.K., et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 8 (2007) 613-624
23. Vikram B. Cancers of the head and neck region in developing countries. Radiother Oncol 67 (2003) 1-2
24. Weissberg J.B., Pillsbury H., Sasaki C.T., Son Y.H., and Fischer J.J. High fractional dose irradiation of advanced head and neck cancer. Implications for combined radiotherapy and surgery. Arch Otolaryngol 109 (1983) 98-102